Efficacy and safety of convalescent plasma and intravenous immunoglobulin in critically ill COVID-19 patients. A controlled clinical trial
Gonzalez et al., medRxiv, doi:10.1101/2021.03.28.21254507
https://c19early.org/gonzalez.html